Meeder Asset Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,378
| Closed | -$341K | – | 2356 |
|
|
2019
Q2 | $341K | Sell |
7,378
-22,691
| -75% | -$1.05M | 0.02% | 469 |
|
|
2019
Q1 | $732K | Buy |
30,069
+27,972
| +1,334% | +$681K | 0.06% | 305 |
|
|
2018
Q4 | $30K | Buy |
2,097
+1,812
| +636% | +$25.9K | ﹤0.01% | 949 |
|
|
2018
Q3 | $4K | Sell |
285
-779
| -73% | -$10.9K | ﹤0.01% | 1385 |
|
|
2018
Q2 | $17.9K | Buy |
1,064
+327
| +44% | +$5.49K | ﹤0.01% | 990 |
|
|
2018
Q1 | $12K | Buy |
+737
| New | +$12K | ﹤0.01% | 1027 |
|
|
2017
Q3 | – | Sell |
-2,129
| Closed | -$18K | – | 1828 |
|
|
2017
Q2 | $18K | Buy |
2,129
+8
| +0.4% | +$68 | ﹤0.01% | 854 |
|
|
2017
Q1 | $19K | Buy |
2,121
+1,657
| +357% | +$14.8K | ﹤0.01% | 738 |
|
|
2016
Q4 | $4K | Buy |
+464
| New | +$4K | ﹤0.01% | 893 |
|